Phenylpiracetam hydrazide

Phenylpiracetam hydrazide, also known as fonturacetam hydrazide,^[1] is a racetam that is a derivative of phenylpiracetam in which the amide group is replaced with a hydrazide group. It was first reported by a Russian research group in 1980 as part of a series of chemical compounds investigated as anticonvulsants.^[2] In an electroshock test it was found to have an ED₅₀ of 310 mg/kg.^[2]

Phenylpiracetam hydrazide

Clinical data
Trade names	Phenylpiracetam hydrazide
Other names	Fonturacetam hydrazide
Pregnancy category	Unknown
Routes of administration	Oral
ATC code	none
Legal status
Legal status	US: Not FDA approved; unscheduled
Identifiers
IUPAC name 2-(2-oxo-4-phenylpyrrolidin-1-yl)acetohydrazide
CAS Number	77472-71-0
PubChem CID	4995664
ChemSpider	4175636 Y
UNII	289199VKN4
CompTox Dashboard (EPA)	DTXSID001032563
Chemical and physical data
Formula	C12H15N3O2
Molar mass	233.271 g·mol−1
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
SMILES c1ccc(cc1)C2CC(=O)N(C2)CC(=O)NN
InChI InChI=1S/C12H15N3O2/c13-14-11(16)8-15-7-10(6-12(15)17)9-4-2-1-3-5-9/h1-5,10H,6-8,13H2,(H,14,16) Y Key:AXQUMNYYLGUJIZ-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Sale on the internet

All piracetam derivatives are not permitted to be sold as dietary supplements in the United States.^[3] However, because they lack scheduling, piracetam derivatives like phenylpiracetam hydrazide are sold over the clear net accompanied by indications stating that the compound is "not for human consumption".^[4]

See also

• Piracetam
• List of Russian drugs